Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 8/20 | 0.49 |
| ▸ | PPARD | Q03181 | 2/20 | 0.48 |
| ▸ | PPARA | Q07869 | 2/20 | 0.48 |
| ▸ | BCL2 | P10415 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25630563 | 0.84 | HTR2A (0.53) | MAOBPPARDPPARABCL2MCL1 | |
| SCHEMBL25420142 | 0.81 | HTR2C (0.66) | MAOBPPARDPPARAPPARG | |
| SCHEMBL30488389 | 0.81 | HTR2C (0.66) | MAOBPPARDPPARAPPARG | |
| SCHEMBL25420145 | 0.81 | HTR2C (0.66) | MAOBPPARDPPARAPPARG | |
| SCHEMBL5894002 | 0.81 | MAPK14 (0.53) | MAOBPPARDPPARABCL2MCL1 | |
| SCHEMBL8959780 | 0.79 | HTR2C (0.59) | SCN9A | |
| SCHEMBL21245274 | 0.78 | BCL2 (0.50) | PPARDPPARABCL2MCL1 | |
| SCHEMBL25421751 | 0.77 | HTR2C (0.47) | MAOBPPARDPPARABCL2MCL1 | |
| SCHEMBL25421755 | 0.77 | HTR2C (0.47) | MAOBPPARDPPARABCL2MCL1 | |
| SCHEMBL30488390 | 0.77 | HTR2C (0.47) | MAOBPPARDPPARABCL2MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023114238-A1 | ARYLOXY PSYCHOPLASTOGENS AND USES THEREOF | DELIX THERAPEUTICS, INC. (US) | 2023-06-22 | — | — | WO | disclosed |